Seed Sheila M, Dunican Kaelen C, Lynch Ann M
Massachusetts College of Pharmacy and Health Science, Worcester, Massachusetts, USA.
Geriatrics. 2009 Oct;64(10):20-9.
Osteoarthritis (OA) is the most common form of arthritis and the leading cause of disability in the United States, especially among older adults. Treatment options have primarily focused on alleviating the pain often associated with this condition. Acetaminophen and nonsteroidal anti inflammatory drugs (NSAIDs) are often employed for relief of mild-to moderate pain associated with OA. NSAIDs are typically more effective than acetaminophen; however, because of adverse effects associated with long-term use of NSAIDS, acetaminophen is considered first-line therapy. Safety concerns of traditional pharmacotherapeutic agents used in the management of OA, such as NSAIDs and opioids, have led healthcare professionals to seek other options. Trials of disease modulating agents that focus on preventing further damage to the joints have the potential to change how this disease state is managed. This article reviews nonpharmacologic and pharmacologic approaches to management of OA of the knee and hip.
骨关节炎(OA)是最常见的关节炎形式,也是美国致残的主要原因,在老年人中尤为如此。治疗方案主要集中在缓解通常与此病症相关的疼痛。对乙酰氨基酚和非甾体抗炎药(NSAIDs)常用于缓解与OA相关的轻至中度疼痛。NSAIDs通常比对乙酰氨基酚更有效;然而,由于长期使用NSAIDs会产生不良反应,对乙酰氨基酚被视为一线治疗药物。用于OA管理的传统药物治疗剂(如NSAIDs和阿片类药物)的安全性问题促使医疗保健专业人员寻求其他选择。专注于预防关节进一步损伤的疾病调节药物试验有可能改变这种疾病状态的管理方式。本文综述了膝关节和髋关节OA管理的非药物和药物方法。